Aiphi Nguyen, PharmD, CEO

​Dr. Aiphi Nguyen, is co-founder and the CEO: Aiphi has more than 18 years’ experience in the pharmaceutical industry and the investment bank with a strong entrepreneurship orientation in goals and choice. Aiphi held various positions with Bristol Myers Squib (BMS) in regulatory, medico-marketing within the peadiatric field for which she gained tractions such as world successful launch of a specific range products intented to the treatment of inborn metabolic disorders, notified in the BMS 2003 annual report.
Then, Aiphi steered her carrier into the investment bank working with valuation team supporting various life sciences mandates. Aiphi has a twofold background in pharmacy and business, is a PharmD and hold an MBA from Sorbone University, a master in corporate finance from ESCP Europe and “Challenge plus” startup certification from HEC.


Manel Kraiem Merabet, PharmD PhD, CDO

Dr Manel Kraiem Merabet is the Chief Development Officer. Manel has more than 9 years of experience in translational and clinical research in cancer centers, hospitals, biotech developing innovating therapies. Prior to Skymab, she served for 6 years as a senior project manager at Innate Pharma where she successfully led all aspects of science, CMC and strategy for multiple ADC projects from lead optimization through candidate selection until IND.
Regarded as an ADC expert, she has been part of discussion panel in World ADC congress in 2022, 2023 and 2024. Manel is a PharmD and hold a PhD in Oncology and immunology from CRCM, a DESC, European radiopharmacy-radiobiology degree from CEA Saclay and Master degree in organic chemistry from Saint Jerome university.



Caroline Mouline, PhD, R&D projects manager

Dr Caroline Mouline is the Director of operations. Caroline has more than 10 years of experience in biotherapies both in academic institution (CNRS, GICC) working in dendritic cells and bispecific antibodies as well as in startup company (Kercell Biosciences) where she co-led as R&D project manager a immunotherapy program in blood diseases.
Caroline is a seasoned scientist in immunotherapy and cell therapy and has an in-depth knowledge in antibody engineering. Caroline holds a PhD in molecular and cell biology from University of Sofia Antipolis